Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Serotonin Uptake Inhibitors (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Serotonin Uptake Inhibitors (administration & dosage) < Serotonin Uptake Inhibitors (adverse effects) < Serotonin Uptake Inhibitors (pharmacokinetics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000137 (1999) W. Meissner [Allemagne] ; T. Schmidt ; A. Kupsch ; T. Trottenberg ; T. LempertReversible leucopenia related to olanzapine.
000139 (1999) D. Mathen [Royaume-Uni] ; C D Marsden ; K P BhatiaSSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia.
000356 (2000) S. Tesei [Italie] ; A. Antonini ; M. Canesi ; A. Zecchinelli ; C B Mariani ; G. PezzoliTolerability of paroxetine in Parkinson's disease: a prospective study.
002922 (2010) Luís Fonseca ; Margarida Rodrigues ; Alvaro MachadoPsychogenic movement disorder after a venlafaxine-induced dystonia.
003A96 (2013) Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François TisonEncephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
004A67 (1995) R A Hauser ; T A ZesiewiczSertraline-induced exacerbation of tics in Tourette's syndrome.
004D64 (1997) F. Ghika-Schmid [Suisse] ; J. Ghika ; P. Vuadens ; J. Bogousslavsky ; F. Regli ; P A DesplandAcute reversible myoclonic encephalopathy associated with fluoxetine therapy.
004D65 (1997) E. Perucca ; E. Marchioni ; D. Soragna ; F. SavoldiFluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity.
004E56 (1997) M. Poyurovsky [Israël] ; M. Schneidman ; A. WeizmanSuccessful treatment of fluoxetine-induced dystonia with low-dose mianserin.
004E91 (1998) R. Kurlan [États-Unis]Acute parkinsonism induced by the combination of a serotonin reuptake inhibitor and a neuroleptic in adults with Tourette's syndrome.
005041 (1998) I M Bronner [Pays-Bas] ; J A VannesteComplex movement disorder associated with fluvoxamine.
005112 (1999) I H Richard [États-Unis] ; A. Maughn ; R. KurlanDo serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Serotonin Uptake Inhibitors (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Serotonin Uptake Inhibitors (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Serotonin Uptake Inhibitors (adverse effects)
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024